Clinical trial
Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ…
NCT00453232 · Cambridge University Hospitals NHS Foundation Trust, Other · Completed
Key facts
| NCT number | NCT00453232 |
|---|---|
| Title | Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors |
| Official title | Accelerated BEP Chemotherapy for Intermediate and High Risk Metastatic Germ Cell Tumor |
| Lead sponsor | Cambridge University Hospitals NHS Foundation Trust, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Extragonadal Germ Cell Tumor, Teratoma, Testicular Germ Cell Tumor |
| Intervention type | Biological, Drug |
| Interventions | bleomycin sulfate, pegfilgrastim, cisplatin, etoposide |
| Enrollment | 20 |
| Start date | Aug 1, 2004 |
| Primary completion | Dec 1, 2008 |
| Completion | Jan 1, 2009 |
| First posted | Mar 28, 2007 |
| Last update posted | Aug 7, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: